[go: up one dir, main page]

CA2087256A1 - Extension circulaire pour produire des complements multiples d'acides nucleiques - Google Patents

Extension circulaire pour produire des complements multiples d'acides nucleiques

Info

Publication number
CA2087256A1
CA2087256A1 CA002087256A CA2087256A CA2087256A1 CA 2087256 A1 CA2087256 A1 CA 2087256A1 CA 002087256 A CA002087256 A CA 002087256A CA 2087256 A CA2087256 A CA 2087256A CA 2087256 A1 CA2087256 A1 CA 2087256A1
Authority
CA
Canada
Prior art keywords
nucleic acid
single strand
template
circular
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002087256A
Other languages
English (en)
Inventor
Jerry L. Ruth
David A. Driver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngene Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2087256A1 publication Critical patent/CA2087256A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
CA002087256A 1990-07-25 1991-07-17 Extension circulaire pour produire des complements multiples d'acides nucleiques Abandoned CA2087256A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55864590A 1990-07-25 1990-07-25
US558,645 1990-07-25
PCT/US1991/005067 WO1992001813A1 (fr) 1990-07-25 1991-07-17 Extension circulaire pour generer plusieurs copies complementaires d'un acide nucleique

Publications (1)

Publication Number Publication Date
CA2087256A1 true CA2087256A1 (fr) 1992-01-26

Family

ID=24230368

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002087256A Abandoned CA2087256A1 (fr) 1990-07-25 1991-07-17 Extension circulaire pour produire des complements multiples d'acides nucleiques

Country Status (5)

Country Link
EP (1) EP0542874A4 (fr)
JP (1) JPH06500014A (fr)
AU (1) AU649066B2 (fr)
CA (1) CA2087256A1 (fr)
WO (1) WO1992001813A1 (fr)

Families Citing this family (136)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE151815T1 (de) * 1990-09-21 1997-05-15 Amgen Inc Enzymatische synthese von oligonukleotiden
US5645987A (en) * 1990-09-21 1997-07-08 Amgen Inc. Enzymatic synthesis of oligonucleotides
US5683874A (en) * 1991-03-27 1997-11-04 Research Corporation Technologies, Inc. Single-stranded circular oligonucleotides capable of forming a triplex with a target sequence
WO1994003624A1 (fr) 1992-08-04 1994-02-17 Auerbach Jeffrey I Procedes d'amplification isothermique de molecules d'acide nucleique
US6261808B1 (en) 1992-08-04 2001-07-17 Replicon, Inc. Amplification of nucleic acid molecules via circular replicons
US6077668A (en) * 1993-04-15 2000-06-20 University Of Rochester Highly sensitive multimeric nucleic acid probes
US7135312B2 (en) 1993-04-15 2006-11-14 University Of Rochester Circular DNA vectors for synthesis of RNA and DNA
US6096880A (en) 1993-04-15 2000-08-01 University Of Rochester Circular DNA vectors for synthesis of RNA and DNA
US5648211A (en) * 1994-04-18 1997-07-15 Becton, Dickinson And Company Strand displacement amplification using thermophilic enzymes
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
WO1997019193A2 (fr) * 1995-11-21 1997-05-29 Yale University Amplication et detection de segments unimoleculaires
WO1997020948A1 (fr) * 1995-12-05 1997-06-12 Koch Joern Erland Reaction d'amplification en cascade d'acide nucleique
GB9609213D0 (en) * 1996-05-02 1996-07-03 Tepnel Medical Ltd Amplification of nucleic acids
JP3415995B2 (ja) * 1996-06-10 2003-06-09 科学技術振興事業団 高分子マイクロ遺伝子重合体の作成方法
GB9626074D0 (en) * 1996-12-16 1997-02-05 Cytocell Ltd Nucleic acids amplification assay
CA2325468C (fr) * 1998-03-25 2008-11-18 Ulf Landegren Replication en cercle roulant destinee a des sondes cadenas
US6316229B1 (en) 1998-07-20 2001-11-13 Yale University Single molecule analysis target-mediated ligation of bipartite primers
US6255082B1 (en) 1998-09-15 2001-07-03 Yale University Artificial long terminal repeat vectors
EP1114184A2 (fr) * 1998-09-15 2001-07-11 Yale University Clonage moleculaire a amplification selon le modele du cercle roulant
AU6471399A (en) * 1998-10-12 2000-05-01 Attomol Gmbh Molekulare Diagnostika Method and kit for directly detecting nucleotide sequences, amino acid sequencesor antigens
GB9822777D0 (en) * 1998-10-20 1998-12-16 Tepnel Medical Ltd Template chain reaction
US6830884B1 (en) 1998-12-15 2004-12-14 Molecular Staging Inc. Method of amplification
US20020025519A1 (en) 1999-06-17 2002-02-28 David J. Wright Methods and oligonucleotides for detecting nucleic acid sequence variations
ATE456575T1 (de) 1999-10-18 2010-02-15 Prince Henrys Inst Med Res Immun-interaktive fragmente der alpha-c- untereinheit von inhibin
CA2360342A1 (fr) 1999-12-02 2001-06-07 Molecular Staging Inc. Generation d'adn circulaire a un seul brin a partir de segments lineaires de renaturation automatique
KR100698561B1 (ko) 2000-01-25 2007-03-21 더 유니버서티 어브 퀸슬랜드 Ｎｅｉｓｓｅｒｉａ Ｍｅｎｉｎｇｉｔｉｄｉｓ 표면 항원ΝｈｈΑ의 보존 부위를 포함하는 단백질
US6221603B1 (en) * 2000-02-04 2001-04-24 Molecular Dynamics, Inc. Rolling circle amplification assay for nucleic acid analysis
US20020004592A1 (en) * 2000-02-10 2002-01-10 Connor James R. Method for amplifying full length single strand polynucleotide sequences
US6291187B1 (en) * 2000-05-12 2001-09-18 Molecular Staging, Inc. Poly-primed amplification of nucleic acid sequences
US6323009B1 (en) 2000-06-28 2001-11-27 Molecular Staging, Inc. Multiply-primed amplification of nucleic acid sequences
AU2001271722B2 (en) 2000-06-30 2006-04-13 Qiagen, Gmbh Signal amplification with lollipop probes
US6312913B1 (en) * 2000-07-21 2001-11-06 Incyte Genomics, Inc. Method for isolating and characterizing nucleic acid sequences
AUPR030900A0 (en) 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
US6573051B2 (en) 2001-03-09 2003-06-03 Molecular Staging, Inc. Open circle probes with intramolecular stem structures
AUPR446701A0 (en) 2001-04-18 2001-05-17 Gene Stream Pty Ltd Transgenic mammals for pharmacological and toxicological studies
WO2004059289A2 (fr) 2001-05-22 2004-07-15 Epicentre Technologies Transcription fonction d'une cible utilisant des mutants de deletion d'arn polymerase n4
GB2378245A (en) 2001-08-03 2003-02-05 Mats Nilsson Nucleic acid amplification method
US7553619B2 (en) 2002-02-08 2009-06-30 Qiagen Gmbh Detection method using dissociated rolling circle amplification
CA2490261A1 (fr) 2002-06-27 2004-01-08 The University Of Queensland Agents de modulation de la differenciation et utilisations associees
US9487823B2 (en) 2002-12-20 2016-11-08 Qiagen Gmbh Nucleic acid amplification
US6977153B2 (en) 2002-12-31 2005-12-20 Qiagen Gmbh Rolling circle amplification of RNA
US20100143442A1 (en) 2003-02-05 2010-06-10 Queensland University Of Technology Growth factor complexes and modulation of cell migration and growth
AU2003900481A0 (en) 2003-02-05 2003-02-20 Queensland University Of Technology Synthetic modulators of cell migration and growth
US8043834B2 (en) 2003-03-31 2011-10-25 Qiagen Gmbh Universal reagents for rolling circle amplification and methods of use
AU2003902253A0 (en) 2003-05-12 2003-05-29 The University Of Queensland Method for increasing product yield
WO2005108608A1 (fr) * 2004-05-10 2005-11-17 Kabushiki Kaisha Dnaform Procédé d'isolation d'isoformes d'acide nucléique
CA2591659A1 (fr) 2004-12-17 2006-06-22 Monash University Regulation du clivage par des metalloproteases de proteines de surface d'une cellule
EP2319940A1 (fr) * 2005-01-04 2011-05-11 Hitachi Chemical Company, Ltd. Amplification de cercle de roulement de génération d'apprêt
GB0504774D0 (en) * 2005-03-08 2005-04-13 Lingvitae As Method
US8309303B2 (en) 2005-04-01 2012-11-13 Qiagen Gmbh Reverse transcription and amplification of RNA with simultaneous degradation of DNA
US8080393B2 (en) 2005-04-12 2011-12-20 Olink Ab Methods for production of oligonucleotides
US7989166B2 (en) 2005-04-12 2011-08-02 In Situ Rcp A/S Circle probes and their use in the identification of biomolecules
EP3492602A1 (fr) 2005-06-15 2019-06-05 Complete Genomics, Inc. Réseaux de molécules simples pour l'analyse génétique et chimique
US20090264299A1 (en) * 2006-02-24 2009-10-22 Complete Genomics, Inc. High throughput genome sequencing on DNA arrays
EP1762627A1 (fr) 2005-09-09 2007-03-14 Qiagen GmbH Procédé pour l'activation d'acides nucléiques pour effectuer une réaction d'une polymérase
CA2624324A1 (fr) 2005-10-06 2007-04-19 Lucigen Corporation Polymerases virales thermostables, et leurs methodes d'utilisation
US7960104B2 (en) * 2005-10-07 2011-06-14 Callida Genomics, Inc. Self-assembled single molecule arrays and uses thereof
US7501254B2 (en) 2006-07-20 2009-03-10 Ghc Technologies, Inc. Methods and compositions for amplification and capture of nucleic acid sequences
KR20090046876A (ko) 2006-08-31 2009-05-11 도요 세이칸 가부시키가이샤 핵산의 증폭방법
US7910354B2 (en) 2006-10-27 2011-03-22 Complete Genomics, Inc. Efficient arrays of amplified polynucleotides
EP2162554A4 (fr) 2007-05-31 2010-07-28 Univ Queensland Marqueurs de diagnostic pour une spondylarthrite ankylosante et leurs utilisations
GB0901593D0 (en) 2009-01-30 2009-03-11 Touchlight Genetics Ltd Production of closed linear DNA
RU2012127364A (ru) 2009-11-30 2014-01-10 Квинсленд Юниверсити Оф Текнолоджи Химеры фибронектин: фактор роста
GB201013153D0 (en) 2010-08-04 2010-09-22 Touchlight Genetics Ltd Primer for production of closed linear DNA
WO2012019168A2 (fr) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Acides nucléiques modifiés et leurs procédés d'utilisation
SG10201508149TA (en) 2010-10-01 2015-10-29 Moderna Therapeutics Inc Engineered nucleic acids and methods of use thereof
DE12722942T1 (de) 2011-03-31 2021-09-30 Modernatx, Inc. Freisetzung und formulierung von manipulierten nukleinsäuren
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
DK3682905T3 (da) 2011-10-03 2022-02-28 Modernatx Inc Modificerede nukleosider, nukleotider og nukleinsyrer og anvendelser deraf
CN110201187A (zh) 2011-12-16 2019-09-06 现代泰克斯公司 经修饰的核苷、核苷酸和核酸组合物
EP3978030A1 (fr) 2012-04-02 2022-04-06 ModernaTX, Inc. Polynucléotides modifiés pour la production de protéines associées à une maladie humaine
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9254311B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US10174366B2 (en) 2012-11-14 2019-01-08 Olink Bioscience Ab Localised RCA-based amplification method
ES2921623T3 (es) 2012-11-26 2022-08-30 Modernatx Inc ARN modificado terminalmente
SG11201507261WA (en) 2013-03-15 2015-10-29 Theranos Inc Nucleic acid amplification
US10450595B2 (en) 2013-03-15 2019-10-22 Theranos Ip Company, Llc Nucleic acid amplification
MX365323B (es) 2013-03-15 2019-05-29 Theranos Ip Co Llc Amplificación de ácidos nucléicos.
WO2014145291A1 (fr) * 2013-03-15 2014-09-18 Theranos, Inc. Amplification d'acide nucléique
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
WO2015034925A1 (fr) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Polynucléotides circulaires
MX2018005873A (es) 2013-09-06 2022-11-17 Labrador Diagnostics Llc Sistemas y metodos para detectar enfermedades infecciosas.
WO2015048744A2 (fr) 2013-09-30 2015-04-02 Moderna Therapeutics, Inc. Polynucléotides codant des polypeptides de modulation immunitaire
BR112016007255A2 (pt) 2013-10-03 2017-09-12 Moderna Therapeutics Inc polinucleotídeos que codificam receptor de lipoproteína de baixa densidade
GB201321123D0 (en) 2013-11-29 2014-01-15 Linea Ab Q Amplification of circular molecules
EP3256591A4 (fr) 2015-02-13 2018-08-08 Translate Bio Ma, Inc. Oligonucléotides hybrides et leurs utilisations
US20170151281A1 (en) 2015-02-19 2017-06-01 Batu Biologics, Inc. Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer
DE112016003948T5 (de) 2015-08-31 2018-05-09 City Of Sapporo Molekulare verfahren zum beurteilen einer urothelialen erkrankung
GB201614023D0 (en) 2016-08-16 2016-09-28 Olink Bioscience Ab Double-stranded circle probes
EP3558355A2 (fr) 2016-12-23 2019-10-30 CureVac AG Vaccin contre l'hénipavirus
EP3558354A1 (fr) 2016-12-23 2019-10-30 CureVac AG Vaccin contre le virus de lassa
EP3558356A2 (fr) 2016-12-23 2019-10-30 CureVac AG Vaccin contre le coronavirus du syndrome respiratoire du moyen-orient
CN110392577A (zh) 2017-03-17 2019-10-29 库尔维科公司 用于组合抗癌疗法的rna疫苗和免疫检查点抑制剂
KR102640361B1 (ko) 2017-05-17 2024-02-23 마이크로바이오 피티와이 엘티디 바이오마커 및 그의 용도
EP3424524B1 (fr) 2017-07-04 2024-12-11 CureVac SE Vaccin à arn contre le cancer
EP3724208A4 (fr) 2017-12-15 2021-09-01 Flagship Pioneering Innovations VI, LLC Compositions comprenant des polyribonucléotides circulaires et leurs utilisations
EP3773702A2 (fr) 2018-04-05 2021-02-17 CureVac AG Nouvelles molécules d'acide nucléique de fièvre jaune pour la vaccination
WO2019202035A1 (fr) 2018-04-17 2019-10-24 Curevac Ag Nouvelles molécules d'arn rsv et compositions pour vaccination
US20210260178A1 (en) 2018-06-27 2021-08-26 Curevac Ag Novel lassa virus rna molecules and compositions for vaccination
AU2019410737A1 (en) 2018-12-21 2021-06-10 CureVac SE RNA for malaria vaccines
CA3125511A1 (fr) 2019-02-08 2020-08-13 Curevac Ag Arn codant administre dans l'espace suprachoroidien pour le traitement de maladies ophtalmiques
MA55082A (fr) 2019-03-01 2022-01-05 Flagship Pioneering Innovations Vi Llc Compositions, procédés, et kits pour l'administration de polyribonucléotides
ES2928724T3 (es) 2019-03-01 2022-11-22 Flagship Pioneering Innovations Vi Llc Polirribonucleótidos y usos cosméticos de los mismos
KR20210135265A (ko) 2019-03-04 2021-11-12 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 원형 폴리리보뉴클레오티드 및 그의 약제학적 조성물
AU2020245548A1 (en) 2019-03-25 2021-10-21 Flagship Pioneering Innovations Vi, Llc Compositions comprising modified circular polyribonucleotides and uses thereof
JP2022537154A (ja) 2019-06-14 2022-08-24 フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー 細胞治療のための環状ｒｎａ
US20220305128A1 (en) 2019-06-19 2022-09-29 Flagship Pioneering Innovations Vi, Llc Compositions comprising circular polyribonucleotides for protein modulation and uses thereof
CN114096674A (zh) 2019-06-19 2022-02-25 旗舰创业创新第六有限责任公司 环状多核糖核苷酸的给药方法
AU2020328855A1 (en) 2019-08-14 2022-03-03 CureVac SE RNA combinations and compositions with decreased immunostimulatory properties
US10980836B1 (en) 2019-12-11 2021-04-20 Myeloid Therapeutics, Inc. Therapeutic cell compositions and methods of manufacturing and use thereof
TW202142239A (zh) 2020-01-29 2021-11-16 美商旗艦先鋒創新有限責任公司 包含環狀多核糖核苷酸之組合物之遞送
CN115361954A (zh) 2020-01-29 2022-11-18 旗舰创业创新第六有限责任公司 用于翻译的组合物及其使用方法
CA3179444A1 (fr) 2020-05-20 2021-11-25 Avak Kahvejian Compositions immunogenes et leurs utilisations
EP4153152A1 (fr) 2020-05-20 2023-03-29 Flagship Pioneering Innovations VI, LLC Compositions et procédés de production d'anticorps polyclonaux humains
CA3179420A1 (fr) 2020-05-20 2021-11-25 Avak Kahvejian Compositions d'antigenes de coronavirus et leurs utilisations
MX2023002439A (es) 2020-09-03 2023-05-09 Flagship Pioneering Innovations Vi Llc Composiciones immunogénicas y usos de las mismas.
WO2022066757A1 (fr) 2020-09-23 2022-03-31 Myeloid Therapeutics, Inc. Procédés et compositions améliorés pour l'expression d'acides nucléiques dans des cellules
JP2023549140A (ja) 2020-11-04 2023-11-22 マイエロイド・セラピューティクス，インコーポレーテッド 操作されたキメラ融合タンパク質組成物およびその使用方法
CA3212398A1 (fr) 2021-03-17 2022-09-22 Daniel Getts Compositions de proteines de fusion chimeriques modifiees et leurs methodes d'utilisation
KR20240122785A (ko) 2021-11-24 2024-08-13 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 면역원성 조성물 및 이의 용도
MX2024006407A (es) 2021-11-24 2024-08-19 Flagship Pioneering Innovations Vi Llc Composiciones de inmunogenos del virus varicela-zoster y sus usos.
CA3239266A1 (fr) 2021-11-24 2023-06-01 Flagship Pioneering Innovations Vi, Llc Compositions immunogenes de coronavirus et leurs utilisations
WO2023115013A1 (fr) 2021-12-17 2023-06-22 Flagship Pioneering Innovations Vi, Llc Procédés d'enrichissement en arn circulaire dans des conditions de dénaturation
WO2023122745A1 (fr) 2021-12-22 2023-06-29 Flagship Pioneering Innovations Vi, Llc Compositions et procédés de purification de polyribonucléotides
CN118922211A (zh) 2021-12-23 2024-11-08 旗舰创业创新六公司 编码抗融合多肽的环状多核糖核苷酸
WO2024097664A1 (fr) 2022-10-31 2024-05-10 Flagship Pioneering Innovations Vi, Llc Compositions et procédés de purification de polyribonucléotides
WO2024192422A1 (fr) 2023-03-15 2024-09-19 Flagship Pioneering Innovations Vi, Llc Compositions immunogènes et leurs utilisations
WO2024192420A1 (fr) 2023-03-15 2024-09-19 Flagship Pioneering Innovations Vi, Llc Compositions comprenant des polyribonucléotides et leurs utilisations
WO2024220712A2 (fr) 2023-04-19 2024-10-24 Sail Biomedicines, Inc. Compositions vaccinales
WO2024220752A2 (fr) 2023-04-19 2024-10-24 Sail Biomedicines, Inc. Compositions thérapeutiques à arn
WO2024220625A1 (fr) 2023-04-19 2024-10-24 Sail Biomedicines, Inc. Administration de polynucléotides à partir de nanoparticules lipidiques comprenant de l'arn et des lipides ionisables
WO2024226621A1 (fr) 2023-04-25 2024-10-31 Ginkgo Bioworks, Inc. Nouveau site d'entrée ribosomique interne (ires) et séquences d'introns
WO2024230934A1 (fr) 2023-05-11 2024-11-14 CureVac SE Acide nucléique thérapeutique pour le traitement de maladies ophtalmiques
WO2025006684A1 (fr) 2023-06-28 2025-01-02 Flagship Pioneering Innovations Vi, Llc Polyribonucléotides circulaires codant pour des polypeptides antifusogènes
WO2025042786A1 (fr) 2023-08-18 2025-02-27 Flagship Pioneering Innovations Vi, Llc Compositions comprenant des polyribonucléotides circulaires et leurs utilisations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6486874A (en) * 1987-09-29 1989-03-31 Sanwa Kagaku Kenkyusho Co Cloned dna containing transcription promoting factor s-ii, its fragment, preparation thereof, plasmid containing said cloned dna or fragment and method for diagnosing viral disease and cancer using said cloned dna or fragment
GB8808892D0 (en) * 1988-04-15 1988-05-18 British Bio Technology Gene synthesis
US4994370A (en) * 1989-01-03 1991-02-19 The United States Of America As Represented By The Department Of Health And Human Services DNA amplification technique
US5001050A (en) * 1989-03-24 1991-03-19 Consejo Superior Investigaciones Cientificas PHφ29 DNA polymerase
US5043272A (en) * 1989-04-27 1991-08-27 Life Technologies, Incorporated Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers
US5071743A (en) * 1989-10-27 1991-12-10 Her Majesty The Queen In Right Of Canada, As Represented By The National Research Council Of Canada Process for conducting site-directed mutagenesis

Also Published As

Publication number Publication date
AU8417391A (en) 1992-02-18
WO1992001813A1 (fr) 1992-02-06
AU649066B2 (en) 1994-05-12
JPH06500014A (ja) 1994-01-06
EP0542874A4 (en) 1994-05-11
EP0542874A1 (fr) 1993-05-26

Similar Documents

Publication Publication Date Title
CA2087256A1 (fr) Extension circulaire pour produire des complements multiples d'acides nucleiques
US5554517A (en) Nucleic acid amplification process
KR960005737B1 (ko) 핵산 배열의 증폭 방법
US5409818A (en) Nucleic acid amplification process
US5824517A (en) Method for amplifying nucleic acid sequences by strand displacement using DNA/RNA chimeric primers
JP4289443B2 (ja) Ｐｃｒの過程でｄｎａ断片の増幅を抑制する方法
JP2788034B2 (ja) ポリヌクレオチドのアツセイのための増幅方法
KR101994494B1 (ko) 조직 샘플 중의 핵산의 국지적 또는 공간적 검출을 위한 방법 및 그 방법의 생성물
EP0676476B1 (fr) Amplification isotherme d'acide nucléique par déplacement d'un brin
JP3421664B2 (ja) ヌクレオチド塩基の同定方法
US5747255A (en) Polynucleotide detection by isothermal amplification using cleavable oligonucleotides
JP3010738B2 (ja) 核酸の交雑、増幅方法
JP2807202B2 (ja) 核酸の高感度検出方法
JP7296409B2 (ja) ポリヌクレオチドシーケンシングに使用するための組成物
JP2004535162A (ja) Ｒｎａ配列の増幅のための方法および組成物
JPH03180184A (ja) リボ核酸（ｒｎａ）の合成方法
JP2003523183A (ja) 固相支持体上の複数のポリヌクレオチドを増幅し、検出する方法
JPH02503054A (ja) 核酸配列の増幅および検出
JP2005508135A (ja) Ｒｎａ配列の増幅のための方法および組成物
JPH048293A (ja) ライゲーシヨン可能なヘアピンプローブ及びその転写を用いた核酸の増巾方法
JP7542444B2 (ja) 配列決定の間のアンラベル化ヌクレオチドによるフェージング減少
JPWO2002062993A1 (ja) 増幅核酸及びその固定化物
JP7562424B2 (ja) シーケンシング用プライマーオリゴヌクレオチド
JP3090100B2 (ja) ホウ素化ヌクレオチドを用いた鎖置換増幅
WO2002059353A2 (fr) Amplification par reaction en chaine de la polymerase (pcr) asymetrique

Legal Events

Date Code Title Description
FZDE Discontinued